INVEX Therapeutics Ltd (IXC) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.171x

Based on the latest financial reports, INVEX Therapeutics Ltd (IXC) has a cash flow conversion efficiency ratio of -0.171x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-779.73K ≈ $-551.71K USD) by net assets (AU$4.55 Million ≈ $3.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is INVEX Therapeutics Ltd worth for the company's overall valuation and market capitalisation.

INVEX Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how INVEX Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

INVEX Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of INVEX Therapeutics Ltd ranked by their cash flow conversion efficiency. Explore INVEX Therapeutics Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Avant Brands Inc TO:AVNT	0.015x
Protektor S.A. WAR:PRT	-0.007x
Kelso Technologies Inc TO:KLS	0.072x
London Security Plc LSE:LSC	0.108x
JPMorgan Indian Inv Trust LSE:JII	-0.006x
Pantera Lithium Ltd AU:PFE	-0.028x
Mitra International Resources JK:MIRA	0.005x
Polar Capital Global Healthcare Trust plc LSE:PCGH	-0.003x

Annual Cash Flow Conversion Efficiency for INVEX Therapeutics Ltd (2019–2025)

The table below shows the annual cash flow conversion efficiency of INVEX Therapeutics Ltd from 2019 to 2025. View IXC stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$5.25 Million ≈ $3.71 Million	AU$-652.57K ≈ $-461.74K	-0.124x	+71.05%
2024-06-30	AU$5.69 Million ≈ $4.02 Million	AU$-2.44 Million ≈ $-1.73 Million	-0.430x	-32.80%
2023-06-30	AU$21.23 Million ≈ $15.02 Million	AU$-6.87 Million ≈ $-4.86 Million	-0.324x	-172.89%
2022-06-30	AU$28.48 Million ≈ $20.15 Million	AU$-3.38 Million ≈ $-2.39 Million	-0.119x	-126.62%
2021-06-30	AU$32.08 Million ≈ $22.70 Million	AU$-1.68 Million ≈ $-1.19 Million	-0.052x	+20.38%
2020-06-30	AU$24.40 Million ≈ $17.27 Million	AU$-1.60 Million ≈ $-1.13 Million	-0.066x	-226.59%
2019-06-30	AU$11.44 Million ≈ $8.09 Million	AU$-230.13K ≈ $-162.83K	-0.020x	--

About INVEX Therapeutics Ltd

AU:IXC Australia Biotechnology

Market Cap

$5.58 Million

AU$7.89 Million AUD

Market Cap Rank

#28475 Global

#1497 in Australia

Share Price

AU$0.11

Change (1 day)

-8.70%

52-Week Range

AU$0.09 - AU$0.16

All Time High

AU$1.67